First Bank & Trust Amgen Inc Transaction History

First Bank & Trust

$510 Million
Q3 2024

A detailed history of First Bank & Trust transactions in Amgen Inc stock. As of the latest transaction made, First Bank & Trust holds 10,689 shares of AMGN stock, worth $3.15 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

10,689

Previous 10,960 2.47%

Holding current value

$3.15 Million

Previous $3.42 Million 0.58%

% of portfolio

0.68%

Previous 0.72%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $83,841 - $91,429	-271 Reduced 2.47%	10,689 $3.44 Million
Q2 2024 Jul 09, 2024	BUY	$262.75 - $319.31 $261,961 - $318,352	997 Added 10.01%	10,960 $3.42 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $519,456 - $627,049	-1,932 Reduced 16.24%	9,963 $2.83 Million
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $367,696 - $414,805	-1,438 Reduced 10.79%	11,895 $3.43 Million
Q3 2023 Oct 11, 2023	BUY	$218.65 - $271.46 $496,991 - $617,028	2,273 Added 20.55%	13,333 $3.58 Million
Q2 2023 Jul 12, 2023	BUY	$214.27 - $253.37 $989,927 - $1.17 Million	4,620 Added 71.74%	11,060 $2.46 Million
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $714,851 - $871,283	-3,166 Reduced 32.96%	6,440 $1.56 Million
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $220,326 - $279,951	962 Added 11.13%	9,606 $2.52 Million
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $241,518 - $272,389	1,076 Added 14.22%	8,644 $1.95 Million
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $104,511 - $116,303	453 Added 6.37%	7,568 $1.84 Million
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $64,246 - $71,073	293 Added 4.29%	7,115 $1.72 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $857,968 - $981,866	4,314 Added 172.01%	6,822 $1.54 Million
Q3 2021 Oct 18, 2021	BUY	$212.27 - $248.7 $44,364 - $51,978	209 Added 9.09%	2,508 $533,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $25,226 - $27,987	108 Added 4.93%	2,299 $560,000
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $2,662 - $3,103	-12 Reduced 0.54%	2,191 $545,000
Q4 2020 Jan 27, 2021	BUY	$216.38 - $257.67 $57,124 - $68,024	264 Added 13.62%	2,203 $507,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $1,173 - $1,304	5 Added 0.26%	1,939 $492,000
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $243,108 - $298,327	1,229 Added 174.33%	1,934 $456,000
Q1 2020 Apr 14, 2020	SELL	$182.24 - $241.7 $366,302 - $485,817	-2,010 Reduced 74.03%	705 $143,000
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $506,136 - $650,560	2,675 Added 6687.5%	2,715 $655,000
Q3 2019 Oct 17, 2019	SELL	$174.11 - $208.62 $1,218 - $1,460	-7 Reduced 14.89%	40 $8,000
Q2 2019 Jul 26, 2019	BUY	$166.7 - $195.41 $1,166 - $1,367	7 Added 17.5%	47 $9,000
Q1 2019 Apr 15, 2019	BUY	$180.87 - $203.88 $7,234 - $8,155	40 New	40 $8,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.

Account